Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Gut
Published September 11, 2026
Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, ...
September 12, 2026
Medspoke
Medspoke
Gut
Published September 11, 2026
00:00
--:--
NCACC maps cross-sample spatial niches and reveals cIgG+ epithelial rare cells driving liver canc...
September 12, 2026
Share
NCACC maps cross-sample spatial niches and reveals cIgG+ epithelial rare cells driving liver cancer invasion.
https://www.medspoke.co/channel_journal?id=785&tap_id=13802
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Blood Advances
Published September 11, 2026
Association between patient-reported symptoms and clinical outcomes in R/R CLL.
September 12, 2026
Why are you reporting this TALK?
